Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design (Q33180329)
scientific article published in May 2000
Language:
Current Data About Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design
(P31) (Q13442814)
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P50) (Q132042279)
(P1545) 1
(P1932) Eskens FA
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P304) 83-88
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P433) 2
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P478) 34
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P577) Monday, May 1, 2000
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P1433) (Q15724423)
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P1476) "Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design" (language: en)
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P2093) Verweij J
(P1545) 2
(P248)
(P698) 10799834
(P813) Sunday, July 23, 2017

(P2860) (Q71803596)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X
(P813) Thursday, January 7, 2021
(P887)

(Q36893821)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X
(P813) Thursday, January 7, 2021
(P887)

(Q40915962)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X
(P813) Thursday, January 7, 2021
(P887)

(Q27860904)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X
(P813) Thursday, January 7, 2021
(P887)

(Q35858587)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X
(P813) Thursday, January 7, 2021
(P887)

(P13046) (Q7318358)
(P248)

other details
description scientific article published in May 2000

External Links
(P356) 10.1016/S1040-8428(00)00055-X
(P698) 10799834